MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ATNM made $6,433K in revenue. -$5,131K in net income. Net profit margin of -79.76%.

Income Overview

Revenue
$6,433K
Net Income
-$5,131K
Net Profit Margin
-79.76%
EPS
-$0.16
Unit: Thousand (K) dollars
Revenue Breakdown
    • Research and development, net of...
    • General and administrative
    • Interest income - net
    • Total revenue

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2024-12-31
2024-09-30
Total revenue-Revenue
-0 --
Total revenue-Other Revenue
-0 --
Total revenue
90 0 --
Research and development, net of reimbursements
4,248 4,879 5,723 9,774
General and administrative
1,534 2,624 2,828 2,827
Total operating expenses
5,782 7,503 8,551 12,601
Loss from operations
-5,692 -7,503 -8,551 -12,601
Interest income - net
561 625 890 1,033
Total other income
561 625 890 1,033
Net loss
-5,131 -6,878 -7,661 -11,568
Net loss per common share basic (in dollars per share)
-0.16 -0.22 -0.26 -0.37
Net loss per common share diluted (in dollars per share)
-0.16 -0.22 -0.26 -0.37
Weighted average common shares outstanding basic (in shares)
31,195,891 31,195,891 -15,552,166 31,071,297
Weighted average common shares outstanding diluted (in shares)
31,195,891 31,195,891 -15,552,166 31,071,297
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income - net$561K Net loss-$5,131K Total other income$561K Revenues$90K Loss from operations-$5,692K Total revenue$90K Total operatingexpenses$5,782K General andadministrative$1,534K Research anddevelopment, net of...$4,248K

Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals, Inc. (ATNM)